Newsletter | May 24, 2023

05.24.23 -- Practical, Innovative Solutions For AAV Development & Manufacturing

Are Real-Time Gene Therapy Test Results Possible?

Along with the complexities of vaccine and viral-based gene therapy process development comes the need for analytical techniques that can help assess quality parameters, especially in real time.

Parallel Approaches, Diverse Partnerships Combat COVID-19

Executives from Moderna, Sanofi Pasteur, Takeda, and Catalent shared behind-the-scenes information on their respective efforts to develop a COVID-19 vaccine. Learn more about the different approaches the companies all adopted as part of a collaborative mindset to arrive at a vaccine as quickly and safely as possible.

ADC Stands Out In The Crowd Of HER2-Targeted Conjugates

Due to its modularity, the SMARTag conjugation platform can be broadly applied to various disease contexts. It leverages ease of analytics and a critical combination of efficacy and tolerability.

Practical, Innovative Solutions For AAV Development, Manufacturing

What are the current challenges and future promises of adeno-associated virus, lentivirus, and lipid nanoparticles in gene therapies? Explore case studies for AAV technology and manufacturing and strategies for navigating the regulatory environments in the U.S. and Europe.